Investor Presentaiton slide image

Investor Presentaiton

Peptide-based drugs market with structural growth momentum Broad therapeutic areas with significant product pipeline Estimated peptide therapeutics end market ($ Bn)(1) 7% CAGR 42 222 39 36 34 32 21F 22F 23F 24F 2020 Based on a study conducted for PolyPeptide Notes: 1. 2. As of Dec-2020 GLOBAL SUPPORT FOR A QUALITY SOLUTION Therapeutic areas for peptide-based drugs (1) Other 30% Metabolic 24% 76 Drugs Approved (2) ~$ 32 Bn 44 Neurological 5% Cardiovascular 8% Oncology 23% 500 Drugs In Development(2) Gastrointestinal 9% 25F 4 Beneficial characteristics of peptides driving strong product pipeline and investments into R&D Expanding applications for peptide drugs āœ“ Increasing incidence of cancer Rising prevalence of metabolic disorders PolyPeptide GROUP
View entire presentation